Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review.

Tumor marker diagnosis malignant pleural effusion (MPE) review

Journal

Translational lung cancer research
ISSN: 2218-6751
Titre abrégé: Transl Lung Cancer Res
Pays: China
ID NLM: 101646875

Informations de publication

Date de publication:
Mar 2021
Historique:
entrez: 23 4 2021
pubmed: 24 4 2021
medline: 24 4 2021
Statut: ppublish

Résumé

Although cytology and pleural biopsy of pleural effusion (PE) are the gold standards for diagnosing malignant pleural effusion (MPE), these tools' diagnostic accuracy is plagued by some limitations such as low sensitivity, considerable inter-observer variation and invasiveness. The assessment of PE biomarkers may hence be seen as an objective and non-invasive diagnostic alternative in MPE diagnostics. In this review, we summarize the characteristics and diagnostic accuracy of available PE biomarkers, including carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), carbohydrate antigens 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), a fragment of cytokeratin 19 (CYFRA 21-1), chitinase-like proteins (CLPs), vascular endothelial growth factor (VEGF) and its soluble receptor, endostatin, calprotectin, cancer ratio, homocysteine, apolipoprotein E (Apo-E), B7 family members, matrix metalloproteinase (MMPs) and tissue-specific inhibitors of metalloproteinases (TIMPs), reactive oxygen species modulator 1 (Romo1), tumor-associated macrophages (TAMs) and monocytes, epigenetic markers (e.g., cell-free microRNA and mRNA). We summarized the evidence from systematic review and meta-analysis for traditional tumor markers' diagnostic accuracy. According to the currently available evidence, we conclude that the traditional tumor markers have high specificity (around 0.90) but low sensitivity (around 0.50). The diagnostic accuracy of novel tumor markers needs to be validated by further studies. None of these tumor biomarkers would have sufficient diagnostic accuracy to confirm or exclude MPE when used alone. A multi-biomarker strategy, also encompassing the use of artificial intelligence algorithms, may be a valuable perspective for improving the diagnostic accuracy of MPE.

Identifiants

pubmed: 33889529
doi: 10.21037/tlcr-20-1111
pii: tlcr-10-03-1557
pmc: PMC8044497
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1557-1570

Informations de copyright

2021 Translational Lung Cancer Research. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tlcr-20-1111). The authors have no conflicts of interest to declare.

Références

Lung Cancer. 2014 Aug;85(2):175-81
pubmed: 24951318
Rejuvenation Res. 2012 Aug;15(4):359-65
pubmed: 22877564
J Mol Med (Berl). 2016 Jul;94(7):739-46
pubmed: 27277824
J Clin Lab Anal. 2007;21(6):398-405
pubmed: 18022924
Clin Chem. 2009 Nov;55(11):1944-9
pubmed: 19696117
Medicine (Baltimore). 2015 Nov;94(47):e2105
pubmed: 26632726
Postgrad Med. 2015 Jun;127(5):529-34
pubmed: 25979108
Respirology. 2012 May;17(4):721-6
pubmed: 22372660
Lung. 2016 Feb;194(1):147-53
pubmed: 26678281
Medicine (Baltimore). 2017 Nov;96(44):e8361
pubmed: 29095265
Clin Chim Acta. 2016 Jun 1;457:81-5
pubmed: 27071700
Br J Cancer. 2010 Mar 30;102(7):1180-4
pubmed: 20216542
Thorax. 2008 Jan;63(1):35-41
pubmed: 17573438
Eur Respir J. 2009 Jan;33(1):134-41
pubmed: 18715875
J Clin Lab Anal. 2018 Oct;32(8):e22576
pubmed: 29797475
Pol Arch Intern Med. 2018 Jun 30;128(6):354-361
pubmed: 29968696
Clin Biochem. 2011 Feb;44(2-3):216-20
pubmed: 21093424
Interact Cardiovasc Thorac Surg. 2016 Apr;22(4):411-8
pubmed: 26769731
Cancer Res. 1993 Jun 15;53(12):2912-8
pubmed: 8504432
Postgrad Med. 2017 Aug;129(6):644-648
pubmed: 28506100
Br J Cancer. 2012 Nov 20;107(11):1876-82
pubmed: 23093228
Lung Cancer. 2001 Jan;31(1):9-16
pubmed: 11162861
Immunobiology. 2012 May;217(5):483-91
pubmed: 21601307
Clin Chim Acta. 1997 Sep 30;265(2):193-205
pubmed: 9385461
Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):263-9
pubmed: 23190621
Transl Res. 2015 Nov;166(5):432-9
pubmed: 25953662
Tohoku J Exp Med. 2017;242(2):137-142
pubmed: 28626164
Cancer Res Treat. 2014 Apr;46(2):178-85
pubmed: 24851110
Cytokine. 2012 Jun;58(3):336-43
pubmed: 22480951
Prog Mol Biol Transl Sci. 2017;147:1-73
pubmed: 28413025
Clin Chim Acta. 2007 Jun;381(2):131-5
pubmed: 17399696
Chin Med J (Engl). 2015 Feb 5;128(3):305-9
pubmed: 25635424
Arch Bronconeumol. 2014 May;50(5):161-5
pubmed: 24360987
Respiration. 2005 Mar-Apr;72(2):166-75
pubmed: 15824527
Thorac Cancer. 2012 Nov;3(4):320-325
pubmed: 28920277
Lung. 2016 Dec;194(6):1021-1027
pubmed: 27677622
Respiration. 2010;80(4):285-91
pubmed: 20453486
Ann Transl Med. 2019 Oct;7(20):554
pubmed: 31807535
Contemp Oncol (Pozn). 2019;23(3):133-140
pubmed: 31798327
Bioanalysis. 2012 Oct;4(19):2367-74
pubmed: 23088463
Int J Biol Sci. 2012;8(8):1197-205
pubmed: 23091417
Br J Cancer. 1999 Nov;81(6):1059-65
pubmed: 10576665
BMJ Open. 2016 Nov 24;6(11):e013324
pubmed: 27884852
Medicine (Baltimore). 2020 Mar;99(10):e19320
pubmed: 32150067
Nat Rev Clin Oncol. 2011 Jun 07;8(8):467-77
pubmed: 21647195
Clin Chest Med. 2013 Sep;34(3):459-71
pubmed: 23993817
Respir Res. 2019 Oct 16;20(1):220
pubmed: 31619240
J Cancer Res Ther. 2016 Dec;12(Supplement):C260-C263
pubmed: 28230031
Med Oncol. 2015 Jan;32(1):312
pubmed: 25491139
Respiration. 2017;94(1):62-69
pubmed: 28427079
Cancer. 2006 Oct 15;107(8):1859-65
pubmed: 16983705
Int J Tuberc Lung Dis. 2009 Mar;13(3):381-6
pubmed: 19275801
BMC Pulm Med. 2018 Dec 6;18(1):188
pubmed: 30522463
Clin Respir J. 2018 Mar;12(3):986-990
pubmed: 28127951
QJM. 2014 Dec;107(12):1001-7
pubmed: 24939190
Cancer. 1999 Oct 15;86(8):1488-95
pubmed: 10526277
J Thorac Dis. 2019 Jul;11(7):2737-2744
pubmed: 31463101
Tumour Biol. 2015 Sep;36(10):7941-5
pubmed: 25956279
J Cancer Res Clin Oncol. 2009 Jul;135(7):919-24
pubmed: 19085002
Oncol Lett. 2012 Mar;3(3):581-585
pubmed: 22740956
Lung. 2003 Nov-Dec;181(6):329-34
pubmed: 14749937
Int J Cancer. 2007 May 15;120(10):2191-5
pubmed: 17285579
Sci Rep. 2020 Mar 30;10(1):5679
pubmed: 32231227
Clin Chim Acta. 2014 Jun 10;433:44-8
pubmed: 24607327
Tumour Biol. 2012 Oct;33(5):1701-7
pubmed: 22684816
Cancer Immunol Immunother. 2015 Aug;64(8):965-76
pubmed: 25944005
Medicine (Baltimore). 2019 Apr;98(14):e14979
pubmed: 30946324
Clin Chim Acta. 2019 Oct;497:48-53
pubmed: 31310745
J Proteomics. 2010 Jun 16;73(8):1511-22
pubmed: 20230924
BMC Cancer. 2010 Oct 28;10:591
pubmed: 21029414
Can Respir J. 2016;2016:7348239
pubmed: 28070157
Biomed Res Int. 2014;2014:419853
pubmed: 25147801
Clin Invest Med. 2009 Aug 01;32(4):E293-300
pubmed: 19640333
Int J Clin Oncol. 2017 Apr;22(2):283-290
pubmed: 27990560
J Thorac Dis. 2019 Jul;11(7):2730-2736
pubmed: 31463100
Curr Probl Cancer. 2019 Aug;43(4):354-362
pubmed: 30471784
Cancer Biomark. 2019;26(4):523-528
pubmed: 31658049
Ther Adv Med Oncol. 2019 May 22;11:1758835919850341
pubmed: 31205509
Intern Med J. 2018 Nov;48(11):1318-1324
pubmed: 29869427
Tumour Biol. 2017 May;39(5):1010428317698378
pubmed: 28459208
BMJ Open. 2014 Feb 24;4(2):e004145
pubmed: 24566531
Cancer Lett. 2017 Oct 28;407:84-92
pubmed: 28807820
Lung Cancer. 2002 Apr;36(1):83-9
pubmed: 11891038
Thorax. 2018 Mar;73(Suppl 1):i1-i30
pubmed: 29444986
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Respirology. 2008 Jun;13(4):518-27
pubmed: 18422869
Clin Chem. 2009 Nov;55(11):1977-83
pubmed: 19745058
Clin Lab. 2017 Sep 1;63(9):1371-1378
pubmed: 28879702
Transl Lung Cancer Res. 2017 Jun;6(3):259-269
pubmed: 28713671
Oncol Lett. 2017 Sep;14(3):3657-3662
pubmed: 28927127
Int J Chron Obstruct Pulmon Dis. 2018 Jan 30;13:409-418
pubmed: 29430175
Biomarkers. 2007 Mar-Apr;12(2):214-20
pubmed: 17536770
Int J Biol Markers. 1995 Jul-Sep;10(3):161-5
pubmed: 8551059
Respir Med. 2004 Feb;98(2):115-22
pubmed: 14971873
Angiogenesis. 2006;9(4):225-30; discussion 231
pubmed: 17109193
Clin Cancer Res. 2003 Jul;9(7):2605-12
pubmed: 12855637
Biomarkers. 2015;20(4):271-4
pubmed: 26301886
Biochem Biophys Res Commun. 2006 Sep 1;347(3):649-55
pubmed: 16842742
J Thorac Dis. 2013 Oct;5(5):634-40
pubmed: 24255777
Anticancer Res. 2018 Dec;38(12):6707-6714
pubmed: 30504380
Medicine (Baltimore). 2017 Jan;96(4):e5975
pubmed: 28121949
Clin Lung Cancer. 2009 Jan;10(1):42-6
pubmed: 19289371
Immunol Rev. 2011 May;241(1):180-205
pubmed: 21488898
Oncotarget. 2017 Jul 25;8(30):49217-49223
pubmed: 28514746
Lung Cancer. 2018 Oct;124:45-52
pubmed: 30268479
J Exp Clin Cancer Res. 2013 Jun 08;32:37
pubmed: 23759037
Tumour Biol. 2012 Oct;33(5):1803-10
pubmed: 22696161
J Thorac Dis. 2016 Jul;8(7):1681-7
pubmed: 27499957
FASEB J. 2005 May;19(7):716-28
pubmed: 15857886
PLoS One. 2013 Dec 27;8(12):e84225
pubmed: 24386354
PLoS One. 2012;7(10):e46091
pubmed: 23056237
BMC Pulm Med. 2015 Dec 01;15:150
pubmed: 26620310
Exp Ther Med. 2015 Jan;9(1):232-238
pubmed: 25452808
Clin Chim Acta. 2013 Jun 5;421:230-5
pubmed: 23523589
BMC Cancer. 2017 Aug 30;17(1):590
pubmed: 28854885
J Thromb Thrombolysis. 2013 Oct;36(3):258-62
pubmed: 23224755
PLoS One. 2019 Sep 24;14(9):e0222616
pubmed: 31550262
Trends Immunol. 2019 Apr;40(4):310-327
pubmed: 30890304
BMJ Open. 2019 Aug 1;9(8):e027287
pubmed: 31375609
Int J Cancer. 2013 Aug 1;133(3):645-52
pubmed: 23354517
Respir Med. 2010 Jan;104(1):149-56
pubmed: 19945835
J Thorac Dis. 2018 May;10(5):2558-2566
pubmed: 29997916
Jpn J Clin Oncol. 2014 Dec;44(12):1198-205
pubmed: 25425729
Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):376-381
pubmed: 29069463
Asian Pac J Cancer Prev. 2012;13(2):505-9
pubmed: 22524815
J Proteome Res. 2005 Jul-Aug;4(4):1274-86
pubmed: 16083277
Clin Chem. 2009 Apr;55(4):623-31
pubmed: 19246618
Ann Transl Med. 2019 Dec;7(23):788
pubmed: 32042804
Oncotarget. 2016 Dec 20;7(51):84851-84859
pubmed: 27769044
Cancer Biomark. 2013;13(1):49-58
pubmed: 23736021
Respiration. 2015;90(3):251-5
pubmed: 26279455
Expert Rev Respir Med. 2015;9(6):801-15
pubmed: 26449328
Acta Oncol. 2007;46(7):1004-11
pubmed: 17917830
J Clin Lab Anal. 2020 Mar;34(3):e23091
pubmed: 31709646
Thorac Cancer. 2021 Jan;12(1):8-12
pubmed: 33225621
J Med Invest. 2007 Feb;54(1-2):146-53
pubmed: 17380026
Comput Methods Programs Biomed. 2018 Jan;153:211-225
pubmed: 29157454
Diagn Cytopathol. 2008 Dec;36(12):849-54
pubmed: 18855882
Respiration. 1996;63(2):106-10
pubmed: 8966363
Exp Ther Med. 2012 Jun;3(6):1072-1076
pubmed: 22970019
Am J Respir Crit Care Med. 2001 Oct 1;164(7):1312-8
pubmed: 11673227

Auteurs

Man Zhang (M)

Department of Thoracic Surgery, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.

Li Yan (L)

Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.

Giuseppe Lippi (G)

Section of Clinical Biochemistry, University of Verona, Verona, Italy.

Zhi-De Hu (ZD)

Department of Laboratory Medicine, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.

Classifications MeSH